Valuation: Medpace Holdings, Inc.

Market Cap 1.82TCr 1.63TCr 1.49TCr 1.36TCr 2.55TCr 1,72700Cr 2.6TCr 18TCr 7.19TCr 91TCr 6.84TCr 6.7TCr 2,87800Cr P/E 2026 *
35.8x
P/E 2027 * 33.2x
Enterprise Value 1.74TCr 1.56TCr 1.43TCr 1.3TCr 2.43TCr 1,65000Cr 2.48TCr 17TCr 6.87TCr 87TCr 6.54TCr 6.4TCr 2,75000Cr EV / Sales 2026 *
6.12x
EV / Sales 2027 * 5.62x
Free-Float
81.13%
Yield 2026 *
-
Yield 2027 * -
1 week-3.92%
Current month-0.28%
1 month+8.46%
3 months+13.42%
6 months+55.92%
Current year+15.77%
1 week 640
Extreme 640
693.97
1 month 590.46
Extreme 590.455
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Exercice

Chief Operating Officer

6,000 0.0215%
07/10/26 Exercice

Chief Operating Officer

4,000 0.0143%
30/09/26 Sell

Chief Executive Officer

-21,966 0.0787%
Change 5-day change 1-year change 3-year change Capi.($)
-0.02%-3.92%+9.46%+145.70% 1.82TCr
-2.37%-4.19%+39.49%+63.21% 6.38TCr
-2.87%+0.49%+10.45%+69.18% 5.64TCr
+0.62%+2.11%+20.22%+102.56% 5.46TCr
-1.92%-4.38%+22.32%+37.36% 4.41TCr
-1.65%-1.84%+16.73%+99.96% 4.21TCr
-0.98%+3.13%+219.66%+796.71% 4.1TCr
-5.47%+24.76%+98.34%+87.34% 3.49TCr
+0.21%-1.23%+14.81%+47.35% 3.28TCr
-1.98%+18.40%-40.66%+341.84% 2.47TCr
Average -1.61%+6.70%+41.08%+179.12% 4.13TCr
Weighted average by Cap. -1.68%+5.28%+43.61%+164.23%

Financials

2026 *2027 *
Net sales 284.96Cr 254.41Cr 233.46Cr 212.37Cr 398.16Cr 27TCr 406.09Cr 2.79TCr 1.12TCr 14TCr 1.07TCr 1.05TCr 45TCr 302.13Cr 269.74Cr 247.53Cr 225.17Cr 422.15Cr 29TCr 430.57Cr 2.96TCr 1.19TCr 15TCr 1.13TCr 1.11TCr 48TCr
Net income 52Cr 46Cr 43Cr 39Cr 73Cr 4.93TCr 74Cr 509.38Cr 205.33Cr 2.6TCr 195.36Cr 191.2Cr 8.22TCr 55Cr 49Cr 45Cr 41Cr 77Cr 5.24TCr 79Cr 541.88Cr 218.43Cr 2.77TCr 207.83Cr 203.4Cr 8.74TCr
Net Debt -81Cr -72Cr -66Cr -60Cr -113.41Cr -7.68TCr -115.67Cr -794.27Cr -320.17Cr -4.06TCr -304.63Cr -298.14Cr -13TCr -127.23Cr -113.59Cr -104.23Cr -95Cr -177.77Cr -12TCr -181.31Cr -1.24TCr -501.84Cr -6.36TCr -477.49Cr -467.31Cr -20TCr
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
02/26/02 $651.15 -0.13% 83,164
30/26/30 $652.01 -3.77% 2,19,452
29/26/29 $677.56 -2.18% 2,50,424
28/26/28 $692.68 +2.80% 3,01,522
27/26/27 $673.79 -0.44% 1,95,611
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
652.01USD
Average target price
651.31USD
Spread / Average Target
-0.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock